Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology

Last updated: July 22, 2021

Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology

Pharm

Pharm

Gastric mucosal protective agents: Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Antiglaucoma medications: Nursing pharmacology
Geriatric considerations - Medications: Nursing
Substance use disorder - Medications and illicit drugs: Nursing
Medications to control airway secretions: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Using an inhaler: Information for patients and families
Non-biologic disease-modifying antirheumatic drug (DMARD) therapy: Nursing pharmacology
Biologic agents: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Glaucoma: Nursing process (ADPIE)
Geriatric considerations - Respiratory: Nursing
Antihyperlipidemics - Statins: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Medication labels: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Medication administration - Insulin: Nursing pharmacology
Antidepressants - SSRIs and SNRIs: Nursing pharmacology
Antidepressants - Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs): Nursing pharmacology
Insulin: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Case study - Wound infection: Nursing
Medication administration - Heparin: Nursing pharmacology
Case study - Healthcare-associated infection (HAI): Nursing
Antibiotics - Fluoroquinolones: Nursing pharmacology
Stimulant medications for attention-deficit hyperactivity disorder (ADHD): Nursing pharmacology
Medication orders: Nursing pharmacology
Medication administration - Safety principles: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Antibiotics - Carbapenems and monobactams: Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Pharmacodynamics: Nursing pharmacology
Analgesics: Nursing pharmacology
Mood stabilizers: Nursing pharmacology
Antipsychotics: Nursing pharmacology
Anxiolytics and sedative-hypnotics: Nursing pharmacology
Antiemetics: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Respiratory stimulants: Nursing pharmacology
Ergot alkaloids: Nursing pharmacology
Antibiotics - Penicillins: Nursing pharmacology
Antitumor antibiotics: Nursing pharmacology
Antibiotics - Macrolides: Nursing pharmacology
Antacids: Nursing pharmacology
Antihistamines: Nursing pharmacology
Laxatives: Nursing pharmacology
Prostaglandins: Nursing pharmacology
Antiarrhythmics: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Antiprotozoals: Nursing pharmacology
Medications for migraines: Nursing pharmacology
Antispasmodics (GU): Nursing pharmacology
Iron preparations: Nursing pharmacology
Leukotriene modifiers: Nursing pharmacology
Nitrates: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Direct-acting vasodilators: Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Cardiac glycosides: Nursing pharmacology
Antivirals for herpesviruses: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Antibiotics - Metronidazole: Nursing pharmacology
Pancreatic enzyme replacements: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Anticoagulants - Heparin: Nursing pharmacology
Vaccines: Nursing pharmacology
Electrolyte balance - Overview: Nursing
Arterial blood gas (ABG) - Respiratory acidosis: Nursing
Antibiotics - Tetracyclines and glycylcyclines: Nursing pharmacology

Notes

ACE INHIBITORS
DRUG TABLE
-pril: e.g., benazepril (Lotensin); lisinopril (Prinivil); captopril (Capoten); ramipril (Altace); enalapril (Vasotec); 
enalaprilat (Vasotec IV)
CLASS
ACE inhibitors
MECHANISM OF ACTION
Block angiotensin-converting enzyme (ACE), preventing it from converting angiotensin I to its active form angiotensin II; decrease aldosterone secretion
INDICATIONS
  • Hypertension
  • Heart failure
  • Post-myocardial infarction
ROUTE(S) OF ADMINISTRATION
  • PO
  • IV (enalaprilat)
SIDE EFFECTS
  • Headache
  • Dizziness
  • Fatigue
  • Constant, dry, irritating cough
  • Angioedema
  • Hypotension
  • Tachycardia
  • Hyperkalemia
CONTRAINDICATIONS AND CAUTIONS
  • Concurrent use of potassium-sparing diuretics
  • Hyperkalemia
  • Boxed warning: pregnancy
NURSING CONSIDERATIONS
Assessment and monitoring
  • Vital signs, ECG, CBC, urinalysis, sodium, potassium, creatinine, and BUN, negative pregnancy test
  • For heart failure: weight, edema, lung sounds, dyspnea
  • Monitor for side effects; have 1:1000 epinephrine available for angioedema

Client education
  • Purpose of medication
  • Side effects
    • Change position slowly to avoid orthostatic hypotension
    • Avoid potassium supplements, salt substitutes, NSAIDs
    • Cough
    • Angioedema
  • Do not stop abruptly 
  • Lifestyle modifications
  • Blood pressure self-monitoring
Author: Antonia Syrnioti, MD
Author: Mary Roberts, MSN, RN
Illustrator: Robyn Hughes, MScBMC

Transcript

Watch video only

Angiotensin converting enzyme inhibitors, or ACE inhibitors for short, are a group of medications that help decrease blood pressure and are typically used to treat hypertension or heart failure, but they can be also administered to clients who have recently had a myocardial infarction.

Now, ACE inhibitors usually end in “-pril”, and include enalapril, lisinopril, ramipril, benazepril, and captopril.

Most of these medications are taken orally, but there’s one ACE inhibitor called enalaprilat that can be administered intravenously for hypertension or severe heart failure when oral treatment isn’t practical. However, it’s not recommended for acute heart failure or myocardial infarction.

Alright, ACE inhibitors work by inhibiting the action of an enzyme called angiotensin-converting enzyme, or ACE for short, preventing it from converting angiotensin I into its active form angiotensin II. Angiotensin II causes blood vessels to constrict, which increases the blood pressure.

In addition, it stimulates the adrenal glands to release aldosterone, which increases reabsorption of sodium and water in the kidneys. This results in increased blood volume, which also contributes to increased blood pressure.

So once ACE inhibitors are administered, there’s less angiotensin II in the bloodstream, which decreases vasoconstriction, as well as decreased aldosterone release by the adrenals, leading to natriuresis, or excretion of sodium along with water by the kidneys. In this way, ACE inhibitors effectively lower the blood pressure.

Now, the most common side effects of ACE inhibitors are mild and nonspecific, such as a headache, dizziness, and fatigue. However, many clients also complain of a constant, dry, irritating cough.

That’s because normally, ACE also breaks down bradykinin, so when the client takes ACE inhibitors, bradykinins accumulate, and they’re thought to induce the cough reflex. In fact, this is a common reason for quitting ACE inhibitors and switching to another medication.

Less frequently, bradykinin accumulation may lead to increased capillary permeability, which results in fluid accumulation and swelling of the eyes, lips, tongue, pharynx, and glottis; this is called angioedema, and can be life threatening.

Other side effects of ACE inhibitors include tachycardia, as well as hypotension, which tends to occur with the first few doses.

Finally, ACE inhibitors decrease potassium excretion in the urine, and this could lead to hyperkalemia, so it’s important for clients who are taking ACE inhibitors to avoid taking potassium supplements and salt substitutes that contain potassium.

As far as contraindications go, ACE inhibitors should be avoided in clients who also take potassium sparing diuretics like spironolactone, or have another underlying cause of hyperkalemia.

Also, ACE inhibitors should be given with caution in those with renal insufficiency. Lastly, as a boxed warning, ACE inhibitors and other medications with a similar mechanism of action are contraindicated during pregnancy, since they may cause fetal injury.

Alright, if your client is prescribed an ACE inhibitor, perform a baseline assessment, including vital signs, ECG, CBC, urinalysis, sodium, potassium, creatinine, and BUN.

For female clients of childbearing age, obtain a negative pregnancy test, and advise them to let their healthcare provider know if they plan to become pregnant.

If the medication is prescribed for heart failure, assess your client’s weight, lung sounds, and for the presence of edema or dyspnea.

Next, be sure to explain why the medication is prescribed and describe common side effects your client should watch for.

Let them know that hypotension can often occur with the first few doses, so instruct your client to be mindful of any feeling of dizziness or weakness, and to make position changes slowly until they adjust to their medication.

Key Takeaways

ACE inhibitors are drugs that lower blood pressure by dilating blood vessels. They work by preventing the conversion of angiotensin I to angiotensin II. Angiotensin II normally constricts blood vessels and raises blood pressure. So, preventing its formation is one of the ways to keep the blood pressure from rising. Some commonly used ACE inhibitors include lisinopril (Prinivil, Zestril), captopril (Capoten), and enalapril (Vasotec).

Sources

  1. "Myasthenia gravis: Molecular mechanisms and promising therapeutic strategies" Biochemical Pharmacology (2023)
  2. "A Practical Approach to Managing Patients with Myasthenia Gravis-Opinions and a Review of the Literature" Front Neurol (2020)
  3. "The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis" Neuropharmacology (2021)
  4. "Pharmacology: A Patient-Centered Nursing Process Approach, 9th edition" Elsevier Canada (2020)
  5. "Acetylcholinesterase Inhibitors in Myasthenic Crisis: A Systematic Review of Observational Studies" Neurocrit Care (2021)
  6. "Karch’s Focus on Nursing Pharmacology, 9th edition" LWW (2023)